rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Wesley Clark

Director

Company insider

Files Form 4 as: Director, ImmunityBio; Director, Rentech; Director, root9B Technologies; Director, Grilled Cheese Truck; Director and Other, Juhl Energy; Director, Rodman & Renshaw Capital Group; Director, Nutracea; Director, Argyle Security.

In numbers

Trades disclosed
88
Buys
9
Sells
7
Bought
$109K
Sold
$138K
Companies
8
Companies where not an officer
8
First trade
1 Feb 2006
Last trade
9 Jun 2026
Last filed
10 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IBRX ImmunityBioDirector · Biotechnology · last 9 Jun 20261 buy · 0 sells
RentechDirector · last 17 Jun 20160 buys · 0 sells
root9B TechnologiesDirector · last 31 May 20162 buys · 7 sells
Grilled Cheese TruckDirector · last 17 Nov 20140 buys · 0 sells
Juhl EnergyDirector, Other · last 19 Mar 20143 buys · 0 sells
Rodman & Renshaw Capital GroupDirector · last 12 Aug 20103 buys · 0 sells
NutraceaDirector · last 19 Oct 20090 buys · 0 sells
Argyle SecurityDirector · last 19 Mar 20090 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 10 Jun 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—65,600 at $0.00filing
9 Jun 2026filed 10 Jun 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—65,600 at $0.00filing
18 Jun 2025filed 20 Jun 2025IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—162,786 at $0.00filing
11 Jun 2024filed 13 Jun 2024IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—77,633 at $0.00filing
13 Jun 2023filed 15 Jun 2023IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—158,263 at $0.00filing
1 Jun 2023filed 5 Jun 2023IBRX ImmunityBioBiotechnologySEC FORM 4 Bought$20K7,000 at $2.91filing
14 Jun 2022filed 15 Jun 2022IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—167,937 at $0.00filing
10 Jun 2021filed 14 Jun 2021IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—26,064 at $0.00filing
3 May 2021filed 5 May 2021IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—21,873 at $0.00filing
17 Jun 2016filed 21 Jun 2016RentechSEC FORM 4 Code A—17,800 at $0.00filing
31 May 2016filed 1 Jun 2016root9B TechnologiesSEC FORM 4 Code M$16K25,000 at $0.65filing
31 May 2016filed 1 Jun 2016root9B Technologiesoption or derivativeSEC FORM 4 Code M—25,000 at $0.00filing
26 May 2016filed 1 Jun 2016root9B TechnologiesSEC FORM 4 Sold$30K25,000 at $1.18filing
25 May 2016filed 31 May 2016root9B TechnologiesSEC FORM 4 Sold$30K25,000 at $1.18filing
23 May 2016filed 31 May 2016root9B TechnologiesSEC FORM 4 Code M$16K25,000 at $0.65filing
23 May 2016filed 31 May 2016root9B Technologiesoption or derivativeSEC FORM 4 Code M—25,000 at $0.00filing
17 May 2016filed 18 May 2016root9B TechnologiesSEC FORM 4 Sold$1,9801,800 at $1.10filing
17 May 2016filed 18 May 2016root9B TechnologiesSEC FORM 4 Code M$16K25,000 at $0.65filing
17 May 2016filed 18 May 2016root9B Technologiesoption or derivativeSEC FORM 4 Code M—25,000 at $0.00filing
16 May 2016filed 18 May 2016root9B TechnologiesSEC FORM 4 Sold$9,0208,200 at $1.10filing

Sectors

Health Care1
Not placed15

Buys in green, sells in red, by the company’s sector.

Related people

Cheryl CohenDirector · Director at ImmunityBio, filing Form 4 there in the last year
Barry J. SimonDirector · Director at ImmunityBio, filing Form 4 there in the last year
Christobel SeleckyDirector · Director at ImmunityBio, filing Form 4 there in the last year
Michael D. BlaszykDirector · Director at ImmunityBio, filing Form 4 there in the last year
Bruce WendelDirector · Director at ImmunityBio, filing Form 4 there in the last year
Lisa C. McClainRepresentative, MI-09 · Also traded IBRX in the last 90 days